Trailing-twelve-month (TTM) revenue is $501.69 Million with a year-over-year growth of (8.37%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $53,869,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $326,238,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-26 |
| Q1 FY2026Period ended 2026-03-31 | $88,018,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $33,566,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $501,691,000 |
Current P/S: $23,751,790 market capitalization ÷ $501,691,000 TTM revenue = 0.05x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T19:15:21.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $33.57M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:16:33.213Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Ancillaries | $27M | $21M | $11M | $11M | $11M | $19M |
| Commission | N/A | N/A | N/A |
$501.69M
$501.69 Million
(8.37%)
vs. $547.52M a year ago (TTM)
(4.10%)
5 Year compound annual growth rate
1 Year
(8.37%)
3 Year
+8.74%
5 Year
(4.10%)
10 Year
+9.66%
15 Year
+7.83%
20 Year
+12.25%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $554.01M | +$21.60M | +4.06% |
| 2024 | $532.41M | +$79.54M | +17.56% |
| 2023 | $452.87M | +$47.52M | +11.72% |
| 2022 | $405.36M | ($132.84M) | (24.68%) |
| 2021 | $538.20M | ($44.58M) | (7.65%) |
| 2020 |
TTM Growth
(8.37%)
3-Year CAGR
+8.74%
5-Year CAGR
(4.10%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T19:16:33.213Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $462M |
| $498M |
| Commission Bonus | $8M | $3M | $2M | -$2M | $4M | $3M |
|---|
| Individual and Family | $27M | $33M | $18M | $17M | $8M | $4M |
|---|
| Medicare | $436M | $426M | $318M | $361M | $427M | $461M |
|---|
| Product and Service, Other | $75M | $45M | $44M | $49M | $71M | $56M |
|---|
| Small Business | $10M | $11M | $12M | $18M | $12M | $11M |
|---|
| $582.77M |
| +$76.57M |
| +15.13% |
| 2019 | $506.20M | +$254.81M | +101.36% |
| 2018 | $251.40M | +$60.69M | +31.82% |
| 2017 | $190.71M | ($2.62M) | (1.35%) |
| 2016 | $193.32M | +$3.78M | +2.00% |
